Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Abortion with Mifepristone and Misoprostol in Singapore
NCT02985229Phase 3Completed
- Sponsor
- Gynuity Health Projects
- Start
- Oct 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone and misoprostol, sponsored by Gynuity Health Projects. Primary endpoint: Rate of successful abortion. Started Oct 2016; status: completed.
02
Drugs
mifepristonemisoprostol
Beyond the preview
Go deeper on NCT02985229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985229.